Fibroma: Clinical Trials

160 trials for Fibroma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 27 recruiting, 19 unknown, 11 active not recruiting. 38 Phase 2, 37 Not applicable, 21 Phase 3, 18 Phase 1, 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 238Completed 22, Recruiting 6, Active not recruiting 4, Unknown 3, Not yet recruiting 1, Terminated 1, Withdrawn 1
Not applicable37Completed 13, Recruiting 10, Unknown 6, Not yet recruiting 5, Active not recruiting 2, Withdrawn 1
Phase 321Completed 16, Active not recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 118Completed 11, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 412Completed 4, Unknown 3, Active not recruiting 2, Recruiting 2, Terminated 1
Early Phase 11Terminated 1

Follow Fibroma: new trials by email Literature Review of Fibroma trials Research Report on Fibroma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
ST316 IV - Familial Adenomatous Polyposis (FAP)
Phase 1Not yet recruitingSapience Therapeutics402027-01-042026-08-12
DEPART Study at Yale
Radiation Therapy - Dupuytren's Contracture
Phase 3Not yet recruitingYale University1582026-11-012026-10-13
Understanding Patient Preferences When Deciding on a Voluntary Musculoskeletal Test
Diagnostic Advance Care Planning Discussion, Informational Statement Only - Non-traumatic Musculoskeletal Conditions, Carpal Tunnel Syndrome (CTS)
Not applicableNot yet recruitingUniversity of Texas at Austin2202026-10-252026-09-22
NAC-REPAIR for Post-surgical Pain
NAC, NAC 0mg/day (Placebo) - Carpal Tunnel Surgery, Trigger Finger Disorder
Phase 2Not yet recruitingUniversity of Arizona802026-10-152026-07-17
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid Tumors
Desmoid tumor ablation - Desmoid Tumor, Aggressive Fibromatoses
Enrolling by invitationMayo Clinic302026-10-012026-09-29
The Impact of Myomectomy on IVF Outcomes: A Multicenter Randomized Controlled Trial
Myomectomy - Infertility, In Vitro Fertilization (IVF)
Not applicableNot yet recruitingPeking Union Medical College Hospital7922026-05-012026-05-11
A Study in Adults With Desmoid Tumors
ES014 - Desmoid Tumor
Phase 2RecruitingElpiscience (Suzhou) Biopharma, Ltd.502026-04-242026-10-21
Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis
Transfer Energy Capacitive and Resistive (TECAR) therapy, Traditional therapy - Palmar Fibromatosis
Not applicableNot yet recruitingCairo University362026-03-022026-03-02
Prognostic Profile of Dupuytren's Disease: a Cohort Study (PRODUCT)
Questionnaires, Clinical examination - Dupuytren's Disease
Not applicableNot yet recruitingGCS Ramsay Santé pour l'Enseignement et la Recherche3052026-02-042026-01-20
Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)
Nirogacestat - Desmoid Tumor, Aggressive Fibromatosis
Phase 4RecruitingSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany502025-09-172026-10-13
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
Nirogacestat oral tablet - Desmoid Tumor, Aggressive Fibromatosis
Phase 2Active not recruitingSpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany202025-08-082026-09-15
Treatment of Desmoid Fibromatosis With Arterial Embolization
embolization therapy - Desmoid Fibromatosis
RecruitingIstituto Ortopedico Rizzoli202025-07-012025-09-12
Immunological Phenotype of Desmoid-fibromatosis-affected Patients.
Desmoid-Type Fibromatosis
RecruitingFondazione IRCCS Istituto Nazionale dei Tumori, Milano2002025-05-272026-03-27
Ultrasound Features of Dupuytren's Disease
Ultrasound assesment, ROM measurement - Dupuytren Disease
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven202025-04-242026-03-16
Evaluating Ultrasound-Guided Needle Knife for Dupuytren's Contracture
Ultrasound guided needle knife dissection - Dupuytren Contracture
Not applicableRecruitingMohamed Maher Ismail Ahmed Elashmawy302025-01-192025-01-27
Skin Involvement in Dupuytren Surgical Treatment Outcome
Suction cutometry, Ultrasound measurement, Microbiopsy for histological analysis - Dupuytren Disease
Not applicableActive not recruitingUniversitaire Ziekenhuizen KU Leuven502024-12-102026-07-10
Electrochemotherapy for Desmoid Tumors
Electrochemotherapy with bleomycin - Desmoid Fibromatosis
WithdrawnIstituto Ortopedico Rizzoli2024-10-172026-05-14
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
Radiation therapy - Dupuytren Contracture
Not applicableRecruitingDartmouth-Hitchcock Medical Center952024-09-162026-07-28
PRISM for Depression and Anxiety in Young Adults With Cancer
Promoting Resilience in Stress Management Program - Cancer Diagnosis, Non-Metastatic Neoplasm
Not applicableCompletedDana-Farber Cancer Institute132024-09-062026-04-21
Safety and Efficacy Study of Collagenase CNT201 Injection for Treatment of Dupuytren's Contracture
[Step1] CNT201 First-dose, [Step1] CNT201 Low-dose, [Step1] CNT201 Intermediate-dose - Dupuytren Contracture, Dupuytren Disease of Finger
Phase 1 / Phase 2RecruitingCONNEXT602024-07-232026-06-12

Showing 20 of 160. Sign in to see all of them.

Narrower conditions

Dupuytren Contracture (75)  ·  Desmoid Tumors (67)  ·  Sarcoma (10)  ·  Neoplasms (9)  ·  Carcinoma, Hepatocellular (7)  ·  Osteosarcoma (7)  ·  Sarcoma, Ewing (7)  ·  Chordoma (6)  ·  Colorectal Neoplasms (6)  ·  Contracture (6)  ·  Endometrial Neoplasms (6)  ·  Melanoma (6)  ·  Trigger Finger Disorder (6)  ·  Carpal Tunnel Syndrome (5)

Broader conditions

Neoplasms by Histologic Type (159)  ·  Neoplasms, Connective Tissue (159)  ·  Neoplasms, Connective and Soft Tissue (159)  ·  Neoplasms, Fibrous Tissue (159)  ·  Neoplasms (151)  ·  Skin and Connective Tissue Diseases (91)  ·  Muscular Diseases (79)  ·  Musculoskeletal Diseases (78)  ·  Connective Tissue Diseases (77)  ·  Contracture (74)  ·  Pathological Conditions, Signs and Symptoms (20)  ·  Neoplasms by Site (18)  ·  Neoplasms, Glandular and Epithelial (17)  ·  Digestive System Diseases (15)

Interventions

Microbial Collagenase (16)  ·  xiapex (12)  ·  nirogacestat (8)  ·  Imatinib Mesylate (5)  ·  Radiotherapy (5)  ·  Collagenases (4)  ·  Cryosurgery (3)  ·  Magnetic Resonance Spectroscopy (3)  ·  Nivolumab (3)  ·  Specimen Handling (3)  ·  Surgical Procedures, Operative (3)  ·  Blood Specimen Collection (2)  ·  Cyclophosphamide (2)  ·  Phantoms, Imaging (2)  ·  Sirolimus (2)

Sponsors

Endo USA Inc., a Keenova Therapeutics Company (13)  ·  Children's Oncology Group (7)  ·  Universitaire Ziekenhuizen KU Leuven (6)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (5)  ·  Istituto Ortopedico Rizzoli (5)  ·  National Cancer Institute (NCI) (4)  ·  SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (4)  ·  University Medical Center Groningen (4)  ·  Mayo Clinic (3)  ·  University Hospital, Strasbourg, France (3)  ·  Cairo University (2)  ·  Centre Oscar Lambret (2)  ·  GCS Ramsay Santé pour l'Enseignement et la Recherche (2)  ·  Indiana Hand to Shoulder Center (2)  ·  Memorial Sloan Kettering Cancer Center (2)

Countries

United States (68)  ·  Canada (16)  ·  Italy (16)  ·  France (15)  ·  Netherlands (12)  ·  Australia (11)  ·  Belgium (11)  ·  United Kingdom (11)  ·  Germany (10)  ·  Spain (7)  ·  China (5)  ·  Denmark (5)  ·  Norway (5)  ·  Puerto Rico (4)  ·  Sweden (4)

Top investigators

Ilse Degreef, Prof. Dr. (5)  ·  Veronica Urdaneta, MD (3)  ·  Veronica Urdaneta, MD, MPPH (3)  ·  Lawrence C Hurst, MD (2)  ·  Lawrence C. Hurst (2)  ·  Steve Skapek, MD (2)  ·  Aaron R Weiss, DO (1)  ·  Achilleas Thoma, MD MSC (1)  ·  Achilleas Thoma, MD MSc FRCSC (1)  ·  AeRang Kim, MD, PhD (1)  ·  Aimee M Crago, MD, PhD (1)  ·  Aldar Bourinbaiar, PhD, MD/PhD (1)

Results publications

PMID 31401903, PMID 17290057, PMID 19451429, PMID 19451433, PMID 19726771, PMID 19768644, PMID 20622000, PMID 21967070, PMID 22480131, PMID 23114473, PMID 23190833, PMID 24089446, PMID 24470559, PMID 24569424, PMID 26602014, PMID 26861905, PMID 27020837, PMID 27064168, PMID 27313184, PMID 28282612, PMID 28350521, PMID 28854973, PMID 28882141, PMID 29983350, PMID 30575484, PMID 30722822, PMID 30786996, PMID 31236956, PMID 31455312, PMID 31969335, PMID 33258687, PMID 33290994, PMID 33362722, PMID 33381769, PMID 33410485, PMID 33483776, PMID 33882143, PMID 34233971, PMID 34380663, PMID 34397515, PMID 34420143, PMID 34716198, PMID 35247923, PMID 35294527, PMID 35938625, PMID 35949922, PMID 36378072, PMID 36758713, PMID 36884323, PMID 37347393

NIH funding

U10CA098543 (2), 2008 (1), 2015 (1), 2016 (1), P30CA008748 (1), P30CA068485 (1), U10CA024507 (1), U10CA031946 (1), U10CA180821 (1), U10CA180886 (1), U10CA180888 (1), UG1CA189958 (1), UM1CA228823 (1)